Related Experiment Videos
Evaluation of community pharmacists' experiences with cholesterol screening programs
1Auburn University, School of Pharmacy, AL 36849-5501, USA. jungnpw@mail.auburn.edu
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|January 13, 1998
Summary
Nebraska pharmacists had limited involvement in cholesterol screenings, with few monitoring the process or following up with patients. This highlights a gap in pharmacist engagement with cardiovascular health initiatives.
Area of Science:
- Pharmacy Practice
- Public Health
- Cardiovascular Disease Prevention
Background:
- Community pharmacists play a role in public health initiatives.
- Cholesterol screening is a key component of cardiovascular disease prevention.
- National guidelines exist for cholesterol screening and patient follow-up.
Purpose of the Study:
- To evaluate the experiences of Nebraska community pharmacists regarding cholesterol screening.
- To assess pharmacist involvement in screening processes and patient follow-up.
- To identify barriers or facilitators to pharmacist participation in cholesterol screening.
Main Methods:
- A mail survey was administered to pharmacists-in-charge of Nebraska community pharmacies.
- The survey assessed experiences with cholesterol screening and patient follow-up.
- Data were analyzed based on responses to survey items.
Main Results:
- 83 out of 308 respondents reported conducting cholesterol screenings.
- While 95% felt screenings were appropriate, only 61% monitored the process.
- Few pharmacists were aware of specific screening procedures or followed up with high-risk patients.
Conclusions:
- Community pharmacists in Nebraska showed limited involvement in cholesterol screening processes.
- There was a low rate of pharmacist initiation of contact with patients referred for physician evaluation.
- Enhanced pharmacist engagement is needed for effective cholesterol management and follow-up.